A retrospective study to determine hepatitis C Virus prevalence and outcomes among pregnant women who injected drugs
Latest Information Update: 28 Dec 2022
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 28 Dec 2022 New trial record
- 08 Nov 2022 Results presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases